Back
Roivant Sciences Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
55
ROIV
Roivant Sciences
Last Price:
11.23
Seasonality Move:
18%
Buy
55
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.10
Seasonality Move:
-1.36%
Buy
55
Roivant Sciences (ROIV)
is a Buy
Is Roivant Sciences a Buy, Sell or Hold?
- The current Roivant Sciences [ROIV] share price is $11.23. The Score for ROIV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ROIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.11. The Score for ADAP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ROIV Stock Price Chart
What is Roivant Sciences's stock price today?
-
The Roivant Sciences share price today is $11.23
The current trend is moderately bullish and ROIV is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
ROIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 52.25 | Buy |
| Chaikin Money Flow: | 731262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.72 - 11.38) | Buy |
| Bollinger Bands (100): | (10.38 - 11.46) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.73 | Sell |
| Chaikin Money Flow: | -768979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.19) | Buy |
| Bollinger Bands (100): | (0.89 - 1.47) | Sell |
ROIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.28 | Sell |
| 20-day SMA: | 11.17 | Buy |
| 50-day SMA: | 10.86 | Buy |
| 200-day SMA: | 10.63 | Buy |
| 8-day EMA: | 11.3 | Sell |
| 20-day EMA: | 11.19 | Buy |
| 50-day EMA: | 11.02 | Buy |
| 200-day EMA: | 10.42 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.16 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.19 | Sell |
| 200-day EMA: | 1.09 | Buy |
Roivant Sciences Earnings Growth & ROIV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.22 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
Roivant Sciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||